Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.410
0.00 (0.00%)
May 5, 2026, 4:00 PM EDT - Market closed
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $53.08 million as of May 5, 2026. Its market cap has decreased by -6.58% in one year.
Market Cap
53.08M
Enterprise Value
-67.06M
1-Year Change
-6.58%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $53.08M, a decrease of -90.57%. That is a compound annual growth rate of -65.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 53.08M | -12.73% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 55.93M |
| PDS Biotechnology | 54.74M |
| Kezar Life Sciences | 54.15M |
| Instil Bio | 53.58M |
| Entera Bio | 51.28M |
| Rallybio | 49.78M |
| Dogwood Therapeutics | 48.77M |
| Radiopharm Theranostics | 48.63M |